/*! * jQuery blockUI plugin * Version 2.70.0-2014.11.23 * Requires jQuery v1.7 or later * * Examples at: http://malsup.com/jquery/block/ * Copyright (c) 2007-2013 M. Alsup * Dual licensed under the MIT and GPL licenses: * http://www.opensource.org/licenses/mit-license.php * http://www.gnu.org/licenses/gpl.html * * Thanks to Amir-Hossein Sobhi for some excellent contributions! */ !function(){"use strict";function e(p){p.fn._fadeIn=p.fn.fadeIn;var b=p.noop||function(){},h=/MSIE/.test(navigator.userAgent),k=/MSIE 6.0/.test(navigator.userAgent)&&!/MSIE 8.0/.test(navigator.userAgent),y=(document.documentMode,"function"==typeof document.createElement("div").style.setExpression&&document.createElement("div").style.setExpression);p.blockUI=function(e){o(window,e)},p.unblockUI=function(e){v(window,e)},p.growlUI=function(e,t,o,n){var i=p('

');e&&i.append("

"+e+"

"),t&&i.append("

"+t+"

"),o===undefined&&(o=3e3);var s=function(e){p.blockUI({message:i,fadeIn:"undefined"!=typeof(e=e||{}).fadeIn?e.fadeIn:700,fadeOut:"undefined"!=typeof e.fadeOut?e.fadeOut:1e3,timeout:"undefined"!=typeof e.timeout?e.timeout:o,centerY:!1,showOverlay:!1,onUnblock:n,css:p.blockUI.defaults.growlCSS})};s();i.css("opacity");i.on("mouseover",function(){s({fadeIn:0,timeout:3e4});var e=p(".blockMsg");e.stop(),e.fadeTo(300,1)}).on("mouseout",function(){p(".blockMsg").fadeOut(1e3)})},p.fn.block=function(e){if(this[0]===window)return p.blockUI(e),this;var t=p.extend({},p.blockUI.defaults,e||{});return this.each(function(){var e=p(this);t.ignoreIfBlocked&&e.data("blockUI.isBlocked")||e.unblock({fadeOut:0})}),this.each(function(){"static"==p.css(this,"position")&&(this.style.position="relative",p(this).data("blockUI.static",!0)),this.style.zoom=1,o(this,e)})},p.fn.unblock=function(e){return this[0]===window?(p.unblockUI(e),this):this.each(function(){v(this,e)})},p.blockUI.version=2.7,p.blockUI.defaults={message:"

Please wait...

",title:null,draggable:!0,theme:!1,css:{padding:0,margin:0,width:"30%",top:"40%",left:"35%",textAlign:"center",color:"#000",border:"3px solid #aaa",backgroundColor:"#fff",cursor:"wait"},themedCSS:{width:"30%",top:"40%",left:"35%"},overlayCSS:{backgroundColor:"#000",opacity:.6,cursor:"wait"},cursorReset:"default",growlCSS:{width:"350px",top:"10px",left:"",right:"10px",border:"none",padding:"5px",opacity:.6,cursor:"default",color:"#fff",backgroundColor:"#000","-webkit-border-radius":"10px","-moz-border-radius":"10px","border-radius":"10px"},iframeSrc:/^https/i.test(window.location.href||"")?"javascript:false":"about:blank",forceIframe:!1,baseZ:1e3,centerX:!0,centerY:!0,allowBodyStretch:!0,bindEvents:!0,constrainTabKey:!0,fadeIn:200,fadeOut:400,timeout:0,showOverlay:!0,focusInput:!0,focusableElements:":input:enabled:visible",onBlock:null,onUnblock:null,onOverlayClick:null,quirksmodeOffsetHack:4,blockMsgClass:"blockMsg",ignoreIfBlocked:!1};var m=null,g=[];function o(e,o){var t,n,i,s,l,d,a,c,r,u=e==window,f=o&&o.message!==undefined?o.message:undefined;(o=p.extend({},p.blockUI.defaults,o||{})).ignoreIfBlocked&&p(e).data("blockUI.isBlocked")||(o.overlayCSS=p.extend({},p.blockUI.defaults.overlayCSS,o.overlayCSS||{}),i=p.extend({},p.blockUI.defaults.css,o.css||{}),o.onOverlayClick&&(o.overlayCSS.cursor="pointer"),s=p.extend({},p.blockUI.defaults.themedCSS,o.themedCSS||{}),f=f===undefined?o.message:f,u&&m&&v(window,{fadeOut:0}),f&&"string"!=typeof f&&(f.parentNode||f.jquery)&&(a=f.jquery?f[0]:f,t={},p(e).data("blockUI.history",t),t.el=a,t.parent=a.parentNode,t.display=a.style.display,t.position=a.style.position,t.parent&&t.parent.removeChild(a)),p(e).data("blockUI.onUnblock",o.onUnblock),r=o.baseZ,a=h||o.forceIframe?p(''):p(''),t=o.theme?p(''):p(''),o.theme&&u?(c='"):o.theme?(c='"):c=u?'':'',r=p(c),f&&(o.theme?(r.css(s),r.addClass("ui-widget-content")):r.css(i)),o.theme||t.css(o.overlayCSS),t.css("position",u?"fixed":"absolute"),(h||o.forceIframe)&&a.css("opacity",0),c=[a,t,r],n=p(u?"body":e),p.each(c,function(){this.appendTo(n)}),o.theme&&o.draggable&&p.fn.draggable&&r.draggable({handle:".ui-dialog-titlebar",cancel:"li"}),s=y&&(!p.support.boxModel||0 .blockUI"):s.find(">.blockUI"),t.cursorReset&&(1 Understanding Boldenone Undecylenate 200 Dosage – Golden

ივნისი 13, 2026

Understanding Boldenone Undecylenate 200 Dosage

Uncategorized

Boldenone Undecylenate, commonly known as Equipoise, is an anabolic steroid that has gained popularity among bodybuilders and athletes for its potent ability to promote lean muscle mass and enhance overall performance. Understanding the appropriate dosage of Boldenone Undecylenate 200 is crucial for achieving desired results while minimizing potential side effects.

https://gymroutines.uk/understanding-boldenone-undecylenate-200-dosage/

Recommended Dosage Guidelines

The dosage of Boldenone Undecylenate can vary based on individual goals, experience levels, and tolerance. Here are some general guidelines:

Beginners: For those new to using anabolic steroids, a dosage of 200-400 mg per week is generally recommended. This helps to assess tolerance and gauge the body’s response.
Intermediate Users: Individuals with prior experience may increase their dosage to 400-600 mg per week. This level typically offers significant muscle gains while maintaining safety.
Advanced Users: Seasoned users may opt for 600-800 mg per week. However, it’s essential to monitor the body closely for any adverse reactions at higher doses.

Injection Frequency

Boldenone Undecylenate has a long half-life, which means it can be injected less frequently compared to other steroids. The standard recommendation is:

Injecting once or twice a week is sufficient to maintain stable blood levels.

Conclusion

Determining the right dosage of Boldenone Undecylenate 200 is vital for achieving your fitness goals while managing risks. Always consult with a healthcare professional or a knowledgeable coach before starting any steroid regimen to ensure safety and effectiveness.

No Comments

Comments are closed.